Editor’s note: A recording of the event is embedded below.
As the biotechnology industry holds its biggest conference, BIO Digital 2021, STAT brings you a look at how Covid-19 has changed the industry. From shifting biotech’s place in the world to a look at what could happen as the world gets back to normal, we’ll cover it all.
- Doug Cole, managing partner, Flagship Pioneering
- Helen Torley, M.B. Ch. B., M.R.C.P., president and chief executive officer, Halozyme Therapeutics
- Kate Sheridan, general assignment reporter, STAT (moderator)
- Solomon Babani, senior vice president, PRA Health Sciences (sponsor introduction)